By Karen Stokes On Wednesday, President Biden was in Las Vegas discussing how his prescription drug law is lowering health care costs and prescription drug prices for seniors across the … [Read more...]
Eli Lilly Heeds President Joe Biden’s Call to Cap the Price of Insulin
By Karen Stokes As part of President Biden’s Inflation Reduction Act, nearly four million seniors on Medicare with diabetes started to see their insulin costs capped at $35 per month this past … [Read more...]
To Help Patients Save Money, Congress Needs to Tackle the Middlemen in Health Care
By Sally C. Pipes As a Republican-controlled House of Representatives with a small majority opens for business in January, one member has especially big ideas for saving patients money on … [Read more...]
340B Doesn’t Solve Health Inequities
By Amy Hinojosa Advocates have long fought for federal funding to reach people in most need. Back in 1992, Congress established the 340B drug pricing program, which guaranteed drug discounts to … [Read more...]
Price Controls Endanger Our Most Vulnerable Communities
By Gary Puckrein Congressional Democrats are still trying to come to an agreement on their social spending bill. On the health care front, lawmakers have been working for months to craft … [Read more...]
“March In” Is Not the Answer
By Howard Dean All Democrats and many Republicans are committed to making prescription drugs more affordable. There is one strategy that is likely to make things worse: overriding patents on … [Read more...]
Price Controls Rob Patients of Future Therapies
By Peter J. Pitts President Donald Trump just announced a sweeping executive order that’d forbid Medicare from paying more for advanced medicines than any other developed country. This price … [Read more...]
Trump’s Socialist Attack on Americans’ Health and Medical Innovations Must be Stopped
By Drew Johnson Imagine if Barack Obama signed an executive order implementing socialist price controls on prescription drugs. And suppose that decision limited the drugs available to patients, … [Read more...]
Trump Administration Ends Pharmacy Coupons When Patients Need Them Most
By Peter J. Pitts For chronically ill Americans, the economic damage from COVID-19 could be nearly as life-threatening as the virus itself. More than 40 million workers have filed for … [Read more...]
Price Controls Punish U.S. Innovators and Economy
By Sally C. Pipes America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the … [Read more...]